U.S. Senate · 118th Congress · S. 2737
FREED of Opioids Act
A bill to require the Food and Drug Administration to determine whether to permit the use of enriched enrollment randomized withdrawal methodology with respect to clinical trials.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Joe Manchin, IIID-WV
- Introduced
- September 7, 2023, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Mike BraunR-IN